Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Anil Kumar Asthana & John Samuel Lubel. (2014) Reactivation of latent viruses after treatment with biological therapies. Virus Adaptation and Treatment 6, pages 1-10.
Read now
Read now
Zhi-Ming Li, Michele Ghielmini & Alden A Moccia. (2013) Managing newly diagnosed follicular lymphoma: state of the art and future perspectives. Expert Review of Anticancer Therapy 13:3, pages 313-325.
Read now
Read now
Ramazan Idilman & Mutlu Arat. (2011) Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation. Expert Review of Anti-infective Therapy 9:8, pages 641-652.
Read now
Read now
Umit Tapan, Sarah K. May, Joseph Fiore & Olga Kozyreva. (2011) Reactivation of hepatitis B virus following bendamustine-containing chemotherapy in a patient with multiple myeloma. Leukemia & Lymphoma 52:5, pages 916-918.
Read now
Read now
Sercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, Didem Sener Dede, Omer Dizdar, Kadri Altundag & Ibrahim Barista. (2007) Rituximab-related viral infections in lymphoma patients. Leukemia & Lymphoma 48:7, pages 1307-1312.
Read now
Read now
Articles from other publishers (31)
Wei Huang, Lingyao Du & Hong Tang. (2021) Hepatitis B virus reactivation: overview and management. Future Virology 16:12, pages 821-835.
Crossref
Crossref
Antoine Jaquet, Simon P. Boni, Kouakou Boidy, Judicaël Tine, Boris Tchounga, Sokhna A. Touré, Jean‐Jacques Koffi, Cherif Dial, Alain Monnereau, Isidore Diomande, Aristophane Tanon, Moussa Seydi, François Dabis, Saliou Diop & Gustave Koffi. (2021)
Chronic viral hepatitis,
HIV
infection and
Non‐Hodgkin
lymphomas in West Africa, a case‐control study
. International Journal of Cancer 149:8, pages 1536-1543.
Crossref
Crossref
Timothy P.W. Jones, Matthew Buckland, Judith Breuer & David M. Lowe. (2019) Viral infection in primary antibody deficiency syndromes. Reviews in Medical Virology, pages e2049.
Crossref
Crossref
J.M. Kim, C.H.D. Kwon, J.-W. Joh, S.W.J. Ko, J.B. Park, S.J. Kim, J.-H. Lee, G.S. Kim, S.J. Kim & S.-K. Lee. (2013) Liver Transplantation in Lymphoma Patients With Hepatitis B Virus Reactivation. Transplantation Proceedings 45:8, pages 2988-2991.
Crossref
Crossref
Yihu Zheng, Shengchu Zhang, Hooi Min Tan Grahn, Chao Ye, Zheng Gong & Qiyu Zhang. (2013) Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis. Hepatitis Monthly 13:4.
Crossref
Crossref
E. Gómez-de la Fuente, L.B. Villalón, L. Calzado-Villarreal, F. Pinedo-Moraleda & J.L. López-Estebaranz. (2012) Splenic Marginal Zone B-Cell Lymphoma with Epidermotropic Skin Involvement. Actas Dermo-Sifiliográficas (English Edition) 103:5, pages 427-431.
Crossref
Crossref
E. Gómez-de la Fuente, L.B. Villalón, L. Calzado-Villarreal, F. Pinedo-Moraleda & J.L. López-Estebaranz. (2012) Linfoma B esplénico de la zona marginal con afectación cutánea epidermotropa. Actas Dermo-Sifiliográficas 103:5, pages 427-431.
Crossref
Crossref
L. K. King, A. Lee & A. Anandacoomarasamy. (2012) Use of biological disease-modifying anti-rheumatic drugs in patients with concurrent rheumatic disease and hepatitis B. Internal Medicine Journal 42:5, pages 523-531.
Crossref
Crossref
Aloysious Aravinthan, William Gelson, Anita Limbu, Rebecca Brais & Paul Richardson. (2012) Hepatic sarcoidosis complicating treatment-naive viral hepatitis. World Journal of Hepatology 4:12, pages 402.
Crossref
Crossref
Lisa J. Toltl & Donald M. Arnold. (2011) Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters. British Journal of Haematology 152:1, pages 52-60.
Crossref
Crossref
Theodoros Kelesidis, George Daikos, Dimitrios Boumpas & Sotirios Tsiodras. (2011) Does rituximab increase the incidence of infectious complications? A narrative review. International Journal of Infectious Diseases 15:1, pages e2-e16.
Crossref
Crossref
DM Arnold, I Nazi, JC Moore, NM Heddle & JG Kelton. 2011. Blood and Bone Marrow Pathology. Blood and Bone Marrow Pathology
157
172
.
Yutaka Tsutsumi, Reiki Ogasawara, Yusuke Kamihara, Shinichi Ito, Yoshiya Yamamoto, Junji Tanaka, Masahiro Asaka & Masahiro Imamura. (2010) Rituximab Administration and Reactivation of HBV. Hepatitis Research and Treatment 2010, pages 1-8.
Crossref
Crossref
Jeryl Villadolid, Kourtney D. LaPlant, Merry Jennifer Markham, David R. Nelson & Thomas J. GeorgeJr.Jr.. (2010) Hepatitis B Reactivation and Rituximab in the Oncology Practice. The Oncologist 15:10, pages 1113-1121.
Crossref
Crossref
Nichola Cooper & Donald M. Arnold. (2010) The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. British Journal of Haematology 149:1, pages 3-13.
Crossref
Crossref
Nichola Cooper & James B. Bussel. (2010) The Long-term Impact of Rituximab for Childhood Immune Thrombocytopenia. Current Rheumatology Reports 12:2, pages 94-100.
Crossref
Crossref
Yutaka TsutsumiYoshiya Yamamoto, Junji Tanaka, Masahiro Asaka, Masahiro Imamura & Nobuo Masauzi. (2009) Prevention of hepatitis B virus reactivation under rituximab therapy. Immunotherapy 1:6, pages 1053-1061.
Crossref
Crossref
Raymond Liang. (2009) How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation. Blood 113:14, pages 3147-3153.
Crossref
Crossref
Steven K. Herrine, Simona Rossi & Victor J. Navarro. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
527
547
.
Yu Xuan Koo, Daniel S. W. Tan, Iain B. Tan, Miriam Tao, Wan Cheng Chow & Soon Thye Lim. (2009) Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy. Cancer, pages NA-NA.
Crossref
Crossref
Laurence Ollier, Catherine Laffont, Aurore Kechkekian, Alain Doglio & Val?rie Giordanengo. (2008) Detection of antibodies to hepatitis B core antigen using the Abbott ARCHITECT? anti-HBc assay: Analysis of borderline reactive sera. Journal of Virological Methods 154:1-2, pages 206-209.
Crossref
Crossref
Ching-Yun Hsieh, Hsin-Hui Huang, Chen-Yuan Lin, Lo Woei Chung, Yu-Mine Liao, Li-Yuan Bai & Chang-Fang Chiu. (2008) Rituximab-Induced Hepatitis C Virus Reactivation After Spontaneous Remission in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology 26:15, pages 2584-2586.
Crossref
Crossref
Dina Attias & Sheila Weitzman. (2008) The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence. Current Opinion in Pediatrics 20:1, pages 17-22.
Crossref
Crossref
Eui Bae KimDae Sik KimSeh Jong ParkYong ParkKyoung Ho RhoSeok Jin Kim. (2008) Hepatitis B Virus Reactivation in a Surface Antigen-negative and Antibody-positive Patient after Rituximab Plus CHOP Chemotherapy. Cancer Research and Treatment 40:1, pages 36.
Crossref
Crossref
Amir Shlomai & Yosef Shaul. (2008) The “metabolovirus” model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon. Medical Hypotheses 71:1, pages 53-57.
Crossref
Crossref
Daisuke Ennishi, Yasuhito Terui, Masahiro Yokoyama, Yuko Mishima, Shunji Takahashi, Kengo Takeuchi, Hiroaki Okamoto, Mitsune Tanimoto & Kiyohiko Hatake. (2007) Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV‐infected CD20‐positive B‐cell lymphoma undergoing rituximab combination chemotherapy. American Journal of Hematology 83:1, pages 59-62.
Crossref
Crossref
Holbrook E. Kohrt, Daniel L. Ouyang & Emmet B. Keeffe. (2007) Antiviral Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus Infection. Clinics in Liver Disease 11:4, pages 965-991.
Crossref
Crossref
Anne Thirot-Bidault, Jaata Ben Mansour, Olivier Lambotte, Caroline Besson, Rita Bou-Farah, Coralie Pallier & Catherine Buffet. (2007) Évolution fatale après réactivation d’une hépatite chronique virale B occulte dans les suites d’une chimiothérapie pour lymphome chez un malade porteur de l’anticorps anti-HBc isolé. Gastroentérologie Clinique et Biologique 31:11, pages 1028-1031.
Crossref
Crossref
Surakit Pungpapong, W. Ray Kim & John J. Poterucha. (2007) Natural History of Hepatitis B Virus Infection: An Update for Clinicians. Mayo Clinic Proceedings 82:8, pages 967-975.
Crossref
Crossref
Nathalie Schnepf, Pierre Sellier, Marc Bendenoun, Jean-Marc Zini, Marie-José Sanson-le pors & Marie-Christine Mazeron. (2007) Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy. Journal of Clinical Virology 39:1, pages 48-50.
Crossref
Crossref
Jeffrey P. Callen. (2007) Complications and Adverse Reactions in the Use of Newer Biologic Agents. Seminars in Cutaneous Medicine and Surgery 26:1, pages 6-14.
Crossref
Crossref